MAPT and Cognitive impairment: Participants with mild (T001 and T002) to moderate (T003 and T004) cognitive impairment displayed pathological levels of total Aβ1−42, phosphorylated and total tau as well as ratios between Aβ1−42/Aβ1−40 and T-tau/Aβ1−42 (Table 1).